Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
(Q35289145)
scientific article
scientific article
Language:
Current Data About
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
other details
description | scientific article |
External Links
(P356) |
10.1073/PNAS.1110814108
|
(P698) |
21933959
|
(P819) |
2011PNAS..10816723Y
|
(P932) |
3189057
|
(P5875) |
51657829
|